GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Achillion Pharmaceuticals, Inc. (ACHN) [hlAlert]

Rating:
Buy ACHN
up 369.37 %

Achillion Pharmaceuticals, Inc. (ACHN) rated Buy by Merriman Curhan Ford

Posted on: Tuesday,  Apr 14, 2009  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) on 04/14/2009, when the stock price was $1.60.
Since then, Achillion Pharmaceuticals, Inc. has gained 369.38% as of 10/07/2015's recent price of $7.51.
If you would have followed this Merriman Curhan Ford's recommendation on ACHN, you would have gained 369.37% of your investment in 2367 days.

Achillion Pharmaceuticals, Inc. (Achillion) is a biopharmaceutical company focused on the discovery, development and commercialization of treatments for infectious diseases. Within the anti-infective market, it focuses on the development of antivirals for the treatment of chronic hepatitis C and the development of antibacterials for the treatment of resistant bacterial infections. As of December 31, 2008, Achillion focused its efforts on advancing two late-stage preclinical candidates: ACH-1095, an NS4A antagonist for the treatment of chronic hepatitis C, being developed in collaboration with Gilead Sciences, Inc. (Gilead), and ACH-1625, a protease inhibitor also for the treatment of chronic hepatitis C. It has a pipeline of other product candidates, for which it is seeking appropriate collaborative partners. These product candidates include elvucitabine for the treatment of human immunodeficiency virus (HIV) infection and ACH-702 for the treatment of serious bacterial infections.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/14/2009 8:25 AM Buy
None
1.60
as of 12/31/2009
1 Week up  29.42 %
1 Month up  105.23 %
3 Months up  169.37 %
1 YTD up  169.37 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy